全身高螺距CT血管成像:降低辐射剂量与对比剂用量的策略
本研究通过体模与150例前瞻性三臂对照,评估双源高螺距CTA采用高浓度(碘帕醇370)低容量(60 mL)对比剂、100 kVp低电压方案,与标准方案(碘帕醇300、75 mL、120 kVp)相比,在血管强化方面非劣效,并可同时降低辐射剂量和对比剂用量。
要点
- 高浓度低容量(碘帕醇370、60 mL)联合100 kVp高螺距CTA的血管强化非劣效于标准方案。
- 100 kVp、240 mAs高螺距方案较120 kVp、250 mAs方案辐射剂量显著降低(p < 0.0001)。
- 各高螺距方案间血管对比强化与管腔内均匀性均无显著差异(p > 0.280、p > 0.191)。
核心结论
- 双源高螺距CTA使用高浓度(碘帕醇370)低容量(60 mL)对比剂与低电压(100 kVp)采集,在血管强化方面非劣效于低浓度(碘帕醇300)标准容量(75 mL)、高电压(120 kVp)方案,并同时降低辐射剂量和对比剂用量而不损害血管对比强化。
研究设计与样本
- 研究含体模实验与前瞻性三臂临床研究,共纳入150例患者,每组50例。
- 第一组接受75 mL碘帕醇300,采集参数120 kVp、250 mAs。
- 第二组接受75 mL碘帕醇370,采集参数100 kVp、240 mAs。
- 第三组接受60 mL碘帕醇370,采集参数100 kVp、240 mAs。
- 体模实验使用金属氧化物半导体场效应晶体管置于拟人体模中提取器官辐射分布,采用方差分析(ANOVA)。
关键影像表现/征象
- 体外实验显示,高浓度(碘帕醇370)低电压(100 kVp)高螺距采集在170 mAs时较低浓度(碘帕醇300)高电压(120 kVp)高螺距采集达到非劣效。
- 辐射评估显示100 kVp、240 mAs方案辐射剂量显著降低(p < 0.0001)。
- 所有高螺距方案间血管对比强化非劣效(p > 0.280),管腔内均匀性无显著差异(p > 0.191)。
- 接受60 mL与75 mL碘帕醇370、100 kVp、240 mAs的两组辐射剂量均显著降低(p < 0.0001)。
诊断标准与关键数值
- 非劣效性在体外于170 mAs时达到。
- 辐射剂量降低的显著性为p < 0.0001(100 kVp、240 mAs方案对比120 kVp、250 mAs方案)。
- 血管对比强化非劣效性检验p > 0.280,管腔内均匀性检验p > 0.191。
临床应用与阅片要点
- 双源高螺距CTA采用高浓度(碘帕醇370)低容量(60 mL)对比剂联合100 kVp低电压采集,可在不损害血管对比强化的情况下同时降低辐射剂量和对比剂用量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: The purpose of this study was to assess the noninferiority of dual-source high-pitch CT angiography (CTA) performed with high-concentration (iopamidol 370) low-volume (60 mL) iodinated contrast material at low voltage (100 kVp) in comparison with dual-source high-pitch CTA with standard-of-care low-concentration (iopamidol 300) standard-volume (75 mL) iodinated contrast material at high voltage (120 kVp) to determine whether use of the high-concentration low-volume method would afford a reduction in radiation dose and contrast volume without negatively affecting vascular opacification.
SUBJECTS AND METHODS: This study had three arms. A phantom was used to assess vascular contrast enhancement at different iodine and saline solution dilutions with iopamidol 300 or 370 to compare lower-iodination (iopamidol 300) high-voltage (120 kVp) high-pitch (120 kVp, 250 mAs) imaging with higher-iodination (iopamidol 370) low-voltage (100 kVp) high-pitch (100 kVp, 100-240 mAs) acquisition. Metal-oxide-semiconductor field-effect transistors were placed in an anthropomorphic phantom to extract organ-based radiation profiles, and ANOVA was performed. The study prospectively enrolled 150 patients: 50 patients received 75 mL iopamidol 300, and image acquisition was performed at 120 kVp and 250 mAs; 50 patients received 75 mL iopamidol 370, and acquisition was performed at 100 kVp and 240 mAs; and 50 patients received 60 mL iopamidol, and acquisition was performed at 370 at 100 kVp and 240 mAs. Vascular signal-to-noise ratio was evaluated at 18 anatomic locations. Longitudinal signal-to-noise ratio was used to assess homogeneity of contrast enhancement. Size-specific dose estimates were calculated. Statistical analyses were performed by ANOVA.
RESULTS: Noninferiority of high-concentration (iopamidol 370) low-voltage (100 kVp) high-pitch acquisitions compared with low-concentration (iopamidol 300) high-voltage (120 kVp) high-pitch acquisition was achieved at 170 mAs in vitro. Radiation assessment showed significant decreases in radiation dose for the 100-kVp 240-mAs protocol (p < 0.0001). Noninferior vascular contrast (p > 0.280) and luminal homogeneity (p > 0.191) were found for all high-pitch protocols. Significantly decreased radiation dose was observed for the two groups that received 60 and 75 mL of iopamidol 370 at 100 kVp and 240 mAs (p < 0.0001).
CONCLUSION: Dual-source high-pitch CTA with high-concentration (iopamidol 370) low-volume (60 mL) iodinated contrast medium and low-voltage acquisition (100 kVp) is noninferior to dual-source high-pitch CTA with low-concentration (iopamidol 300) standard-volume (75 mL) iodinated contrast material at high voltage (120 kVp) and affords simultaneous reduction in radiation dose and contrast volume without negatively affecting vascular contrast enhancement.
引用
- Manneck S, Hurwitz LM, Seaman DM, et al. Whole-Body High-Pitch CT Angiography: Strategies to Reduce Radiation Dose and Contrast Volume. AJR Am J Roentgenol. 2017. PMID: 28981350. doi:10.2214/AJR.16.17695
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。